معرفی
Dr. Luis Alameda is a Senior Clinical Lecturer at King's College London's Department of Psychosis Studies and a Consultant Psychiatrist at South London and Maudsley NHS Foundation Trust. He holds an MD and PhD, with training across Sevilla, Lund, Florence, and Lausanne. His research focuses on the interplay between childhood adversity, epigenetics, and psychosis mechanisms, particularly in early intervention. He has led programs like TIPP (Treatment and Early Intervention in Psychosis Program) and contributed to large-scale studies such as EU-GEI and STRATA-G consortia.
Education: MD from Universidad de Sevilla, PhD from King's College London (2022). Awards include the Kings Outstanding Prize (2022), European Psychiatric Association Research Prize (2019), and multiple Young Investigator Awards. His work emphasizes translational research to improve clinical outcomes and service development for psychosis patients.
Key research areas include epigenetic biomarkers, cannabis use mediation, and polygenic risk in psychosis. He has published over 30 peer-reviewed articles and collaborates internationally. Current projects involve predictive models for treatment resistance and early intervention strategies.
